Volume 22, Number 1—January 2016
CME ACTIVITY - Synopsis
Epidemiology of Haemophilus ducreyi Infections
Table 1
Area, reference† | Country | Year of study | Diagnostic method | No. patients with GUD | No. cases H. ducreyi infection | % (95% CI) |
---|---|---|---|---|---|---|
Africa | ||||||
Paz-Bailey et al. (16) | Botswana | 1993 | Culture | 108 | 27 | 25.0 (17.7–33.9) |
Steen (17) | Côte d’Ivoire | 1996 | PCR | NA | NA | 47 |
Mabey et al. (18) | Gambia | 1987 | Culture | 104 | 54 | 51.9 (42.4–61.2) |
Hawkes et al. (19) | Gambia | 1995 | M-PCR | 18 | 8 | 44.4 (24.5–66.2) |
Nsanze et al. (20) | Kenya | 1980 | Culture | 97 | 60 | 61.8 (51.9–70.9) |
Kaul et al. (21) | Kenya | 1997 | Culture | 189 | 54 | 28.5 (22.6–35.3) |
Morse et al. (22) | Lesotho | 1994 | M-PCR | 105 | 55 | 53.3 (43.8–62.6) |
Harms et al. (23) | Madagascar | 1992 | Culture | 12 | 61 | 19.6 (11.6–31.3) |
Behets et al. (24) | Madagascar | 1997 | M-PCR | 196 | 64 | 32.6 (26.4–39.5) |
Behets et al. (25) | Malawi | 1995 | M-PCR | 778 | 204 | 26.2 (23.2–29.4) |
Hoyo et al. (26) | Malawi | 1999 | M-PCR | 137 | 41 | 29.0 (22.8–38.0) |
Bogaerts et al. (27) | Rwanda | 1992 | Culture | 395 | 115 | 29.1 (24.8–33.7) |
Totten et al. (28) | Senegal | 1992 | PCR | 39 | 22 | 56.4 (40.9–70.7) |
Crewe-Brown et al. (29) | South Africa | 1981 | Culture | 100 | 45 | 45 (35.5–54.7) |
Dangor et al. (30) | South Africa | 1989 | Culture | 240 | 164 | 68.3 (62.2–73.8) |
Cheng et al. (31) | South Africa | 1994 | M-PCR | 538 | 171 | 31.7 (27.9–35.8) |
Lai et al. (32) | South Africa | 1994 | M-PCR | 160 | 232 | 68.9 (62.7–74.5) |
South Africa | 1998 | M-PCR | 94 | 186 | 50.5 (43.4–57.6) | |
Meheus et al. (33) | Swaziland | 1979 | Culture | 155 | 68 | 43.8 (36.3–51.7) |
Ahmed et al. (34) | Tanzania | 1999 | PCR | 102 | 12 | 11.7 (6.8–19.4) |
Le Bacq et al. (35) |
Zimbabwe |
1991 |
Culture |
90 |
22 |
24.4 (16.7–34.2) |
Asia | ||||||
Wang et al. (36) | China | 1999 | M-PCR | 96 | 0 | 0.0 (0.0–3.8) |
Risbud et al. (37) | India | 1994 | M-PCR | 302 | 84 | 27.8 (23.0–33.1) |
Rajan et al. (38) | Singapore | 1983 | Culture | 670 | 56 | 8·3 (6·4–10·7) |
Beyrer et al. (15) |
Thailand |
1996 |
M-PCR |
38 |
0 |
0.0 (0.0–9.1) |
North America | ||||||
Dillon et al. (39) | United States | 1990 | Culture | 82 | 27 | 32.9 (23.7–43.6) |
Mertz et al. (40) | United States | 1995 | M-PCR | 143 | 56 | 39.1 (231.5–47.3) |
Mertz et al. (41) |
United States |
1996 |
M-PCR |
516 |
16 |
3.1 (1.9–4.9) |
South America | ||||||
Sanchez et al. (42) |
Peru |
1995 |
M-PCR |
61 |
3 |
4.9 (1.6–13.4) |
Caribbean | ||||||
Sanchez et al. (42) | Dominican Republic | 1996 | M-PCR | 81 | 21 | 25.9 (17.6–36.4) |
Behets et al. (43) | Jamaica | 1996 | M-PCR | 304 | 72 | 23·6 (19.2–28.7) |
Bauwens et al. (44) |
Bahamas |
1992 |
PCR |
47 |
7 |
14·8 (7.4–27.6) |
Middle East | ||||||
Madani et al. (45) |
Saudi Arabia |
1999 |
Culture |
3,679 |
78 |
2.1 (1.7–2.5) |
Europe | ||||||
Kyriakis et al. (46) | Greece | 1996 | Culture | 695 | 32 | 4.6 (3.2–6.4) |
Bruisten et al. (47) | The Netherlands | 1996 | M-PCR | 368 | 3 | 0.8 (0.2–2.3) |
*GUD, genital ulcer disease; NA, not available; M-PCR, multiplex PCR.
†References 41–47 provided in the online Technical Appendix (http://wwwnc.cdc.gov/EID/article/22/1/15-0425-Techapp1.pdf).
Page created: December 17, 2015
Page updated: December 17, 2015
Page reviewed: December 17, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.